Nimodipine is well characterized for the management of
aneurysmal subarachnoid hemorrhage and has been shown to promote a better outcome and less delayed ischemic neurological deficits. Animal and clinical trials show neuroprotective efficacy following nerve
injuries. We showed a
neuroprotective effect on Neuro2a cells. Subsequent microarray analysis revealed-among others-
fatty acid 2-hydroxylase (FA2H) upregulated by
nimodipine in vitro, which is a component of myelin synthesis. Differentiated Neuro2a cells were analyzed for
nimodipine-mediated survival considering stress treatment in comparison to
nifedipine-treatment. Cell survival was determined by measurement of LDH activity in the culture medium.
Nimodipine decreased surgery-like stress-induced cell death of differentiated Neuro2a cells. Neuro2a cell culture was analyzed for changes in FA2H expression induced by
nimodipine or
nifedipine in surgery-like stress conditions. We analyzed expression levels of FA2H
mRNA and
protein by qPCR using fa2h specific primers or a FA2H-specific antibody in
nimodipine or
nifedipine non- and pre-treated Neuro2a cell culture, respectively.
Nimodipine but not
nifedipine increases FA2H
protein levels and also significantly increases
mRNA levels of FA2H in both undifferentiated and differentiated Neuro2a cells. Our findings indicate that higher expression of FA2H induced by
nimodipine may cause higher survival of Neuro2a cells stressed with surgery-like stressors.